Published ahead of print on February 15, 2007, doi:10.1164/rccm.200607-908OC
American Journal of Respiratory and Critical Care Medicine Vol 175. pp. 919-925, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200607-908OC
Cigarette Smoking Alters Bronchial Mucosal Immunity in Asthma
Maria Tsoumakidou1,2,
William Elston1,3,
Jie Zhu1,
Zhuo Wang1,
Elizabeth Gamble4,
Nikos M. Siafakas2,
Neil C. Barnes3 and
Peter K. Jeffery1
1 Lung Pathology Unit, Department of Gene Therapy, Imperial College London, London, United Kingdom; 2 Thoracic Medicine, Department of Internal Medicine, University of Crete, Heraklion, Greece; 3 Respiratory Medicine, St Barts and the London Hospital Trust, London, United Kingdom; and 4 Respiratory Medicine, Bristol Royal Infirmary, Bristol, United Kingdom
Correspondence and requests for reprints should be addressed to Peter K. Jeffery, FRCPath., D.Sc., Lung Pathology, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK. E-mail: p.jeffery{at}imperial.ac.uk
Rationale: Cigarette smoking worsens asthma and is associated with reduced response to corticosteroid therapy. As cigarette smoke is known to have immunomodulatory effects, we hypothesized that one mechanism by which smoking mediates its adverse effect is by reduction of the numbers of bronchial mucosal dendritic cells (DCs), which control B-cell growth and T-cell responses.
Objectives: We set out to sample the bronchial mucosa in smoking and never-smoking patients with asthma and to count DCs, B cells, and cells expressing genes for two key T-lymphocyte regulatory cytokines.
Methods: Twenty-one never-smoker patients with asthma (6 steroid naive), 24 smoker patients with asthma (9 steroid naive), and 10 healthy never-smokers (control subjects) were recruited and their endobronchial biopsy samples were immunostained for detection of mature DCs (CD83+), Langerhans cells (CD1a+), B lymphocytes (CD20+), and helper T-cell type 1 (IFN- ) and helper T-cell type 2 (IL-4) cytokineexpressing cells.
Measurements and Main Results: The number (per square millimeter) of CD83+ mature DCs was significantly lower in smoker patients with asthma (median [range]: 37 [0, 131]) in comparison with never-smoker steroid-naive and steroid-treated patients with asthma (76 [24, 464]; p = 0.006) or control subjects (85 [40, 294]; p = 0.004). Moreover, B cells were fewer in smoker (26 [4, 234]) versus never-smoker steroid-naive and steroid-treated patients with asthma (45 [10, 447]; p = 0.01) and in smoker steroid-naive patients with asthma (23 [4, 111]) versus control subjects (34 [10, 130]; p = 0.05). The number of cells expressing IFN- showed a trend toward fewer in smoker (70 [6, 24]) versus never-smoker steroid-naive patients with asthma (144 [44, 323]; p = 0.10).
Conclusions: There are important and statistically significant differences in the number of CD83+ mature DCs and B cells in the large airways of smokers with asthma. We speculate that their reductions may render patients with asthma less responsive to corticosteroids and more susceptible to infection.
Key Words: asthmatic smoker inflammation dendritic cells lymphocytes
| AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
Smoking may worsen asthma and render it less responsive to the beneficial effects of inhaled steroid therapy. Cigarette smoke impairs the function of dendritic cells and alters their number.
What This Study Adds to the Field
One mechanism by which smoking mediates its adverse effects in asthma is by reduction of the numbers of bronchial mucosal dendritic cells.
|
This article has been cited by other articles:

|
 |

|
 |
 
Y.-M. Tseng, S.-M. Tsai, S.-Y. Chen, C.-C. Lin, Y.-R. Jin, W.-H. Yeh, Y.-R. Wu, I.-J. Chen, J.-H. Lee, and L.-Y. Tsai
Roles of the Genetic Polymorphisms of Alcohol-Metabolizing Enzymes on the Immunology in High-Risk Drinkers
Toxicol. Sci.,
October 1, 2009;
111(2):
267 - 276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tsoumakidou, A. V. Koutsopoulos, N. Tzanakis, K. Dambaki, E. Tzortzaki, S. Zakynthinos, P. K. Jeffery, and N. M. Siafakas
Decreased Small Airway and Alveolar CD83+ Dendritic Cells in COPD
Chest,
September 1, 2009;
136(3):
726 - 733.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Kane, U. Kolsum, T. Southworth, J. Armstrong, A. Woodcock, and D. Singh
The Effects of Smoking on the Lipopolysaccharide Response and Glucocorticoid Sensitivity of Alveolar Macrophages of Patients With Asthma
Chest,
July 1, 2009;
136(1):
163 - 170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bratke, M. Klug, A. Bier, P. Julius, M. Kuepper, J. C. Virchow, and M. Lommatzsch
Function-Associated Surface Molecules on Airway Dendritic Cells in Cigarette Smokers
Am. J. Respir. Cell Mol. Biol.,
June 1, 2008;
38(6):
655 - 660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tsoumakidou, I. K. Demedts, G. G. Brusselle, and P. K. Jeffery
Dendritic Cells in Chronic Obstructive Pulmonary Disease: New Players in an Old Game
Am. J. Respir. Crit. Care Med.,
June 1, 2008;
177(11):
1180 - 1186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. C. Moore
Update in Asthma 2007
Am. J. Respir. Crit. Care Med.,
May 15, 2008;
177(10):
1068 - 1073.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I Sabroe, L C Parker, P M A Calverley, S K Dower, and M K B Whyte
Pathological networking: a new approach to understanding COPD
Postgrad. Med. J.,
May 1, 2008;
84(991):
259 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A V Rogers, E Adelroth, K Hattotuwa, A Dewar, and P K Jeffery
Bronchial mucosal dendritic cells in smokers and ex-smokers with COPD: an electron microscopic study
Thorax,
February 1, 2008;
63(2):
108 - 114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tsoumakidou and P. K. Jeffery
Dendritic Cell Maturity and Obstructive Airway Disease
Am. J. Respir. Crit. Care Med.,
October 15, 2007;
176(8):
833 - 833.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. K. Demedts, G. F. Joos, and G. G. Brusselle
Dendritic Cell Maturity and Obstructive Airway Disease
Am. J. Respir. Crit. Care Med.,
October 15, 2007;
176(8):
833 - 834.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Sabroe, L. C Parker, P. M A Calverley, S. K Dower, and M. K B Whyte
Pathological networking: a new approach to understanding COPD
Thorax,
August 1, 2007;
62(8):
733 - 738.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 American Thoracic Society
|
|
|